NYSE: DHRDanaher Corp Stock
$324.13-0.57 (-0.18%)
Updated Sep 22, 2021
DHR Price
$324.13
Fair Value Price
N/A
Market Cap
$231.40B
52 Week Low
$201.44
52 Week High
$333.96
P/E
42.43x
P/B
5.41x
P/S
7.33x
PEG
3.39x
Dividend Yield
0.24%
Revenue
$26.72B
Earnings
$5.61B
Gross Margin
59.2%
Operating Margin
26.36%
Profit Margin
20.4%
Debt to Equity
0.83
Operating Cash Flow
$8B
Beta
0.81
Next Earnings
Oct 20, 2021
Ex-Dividend
Sep 29, 2021
Next Dividend
Oct 29, 2021
Zen Score
High
Medium
Low
43
Industry average
Reasons for this score
DHR ($324.13) is trading below its intrinsic value of $443.25, according to Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Valuation
DHR is good value based on its earnings relative to its share price (42.43x), compared to the US market average -10.34x)
Valuation
DHR is poor value based on its earnings relative to its share price (42.43x), compared to the US Diagnostics & Research industry average (33.05x)
Valuation
DHR News
Valuation
DHR price to earnings (PE)
For valuing profitable companies with steady earnings
Company
42.43x
Industry
33.05x
Market
-10.34x
DHR is good value based on its earnings relative to its share price (42.43x), compared to the US market average -10.34x)
Valuation
DHR is poor value based on its earnings relative to its share price (42.43x), compared to the US Diagnostics & Research industry average (33.05x)
Valuation
DHR price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
5.41x
Industry
6.7x
DHR is good value based on its book value relative to its share price (5.41x), compared to the US Diagnostics & Research industry average (6.7x)
Valuation
DHR price to earnings growth (PEG)
For valuing profitable companies with growth potential
DHR is poor value relative to its rate of earnings growth, measured by PEG ratio (3.39x)
Valuation
DHR's financial health
Profit margin
Revenue
$7.2B
Net Income
$1.8B
Profit Margin
24.2%
DHR's Earnings (EBIT) of $7.04B can safely cover interest payments on company debt ($20.42B)
Financials
DHR's profit margin has increased (+2.5%) in the last year from (17.9%) to (20.4%)
Financials
Assets to liabilities
Assets
$78.0B
Liabilities
$35.3B
Debt to equity
0.48
DHR's short-term assets ($15.39B) exceed its short-term liabilities ($6.83B)
Financials
DHR's long-term liabilities ($28.44B) exceed its short-term assets ($15.39B)
Financials
DHR's debt relative to shareholder equity (0.83) has decreased or remained constant compared to 5 years ago (1.05)
Financials
DHR's debt to equity ratio (0.83) is considered high
Financials
Cash flow
Operating
$2.1B
Investing
-$1.1B
Financing
-$139.0M
DHR's operating cash flow ($7.94B) is sufficient to service the company's debt ($20.42B)
Financials
Danaher Corp Stock FAQ
©2021 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.